The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.
Pandemic Poses a Crucial Moment for Science and the Public TrustJune 2nd 2020
At this moment, we should consider what it will take for the scientific community as a collective entity to self-regulate far more forcefully so that the actions of a limited number of its members do not squander the well-deserved awakening of public trust in the entire scientific enterprise.
Chowdhary Covers Risk-Reducing Strategies and Recommendations During the COVID-19 EraJune 2nd 2020
Mudit Chowdhary, MD, shares advice for family members living with patients with cancer, projects the long-term implications of the COVID-19 pandemic on clinical practice, provides insight on the effects of investigational treatments for patients with COVID-19, and details the protocols Rush University Medical Center has put into place to limit the spread of the virus.
Active Cancer Strongly Associated With Increased COVID-19 Mortality
An analysis of data collected in the COVID-19 and Cancer Consortium registry showed that patients with progressive cancer were 5.2-times more likely to die within 30 days of being diagnosed with novel coronavirus 19 compared with patients in remission or with no evidence of disease.
Dr. Burris and Dr. Graff Talk COVID-19 and Cancer Care, Telemedicine, and ASCO InitiativesMay 25th 2020
Howard A. "Skip" Burris, III, MD, FASCO, FACP, and Stephanie L. Graff, MD, discuss how the COVID-19 pandemic has affected cancer care, the collaborative efforts made between Sarah Cannon Research Institute and HCA to increase access to investigational COVID-19 treatments, and the steps ASCO has taken to ensure its members’ professional education and well-being during this time.
Mindful Adaptation of Breast Cancer Treatment Necessary Amid COVID-19 CrisisMay 24th 2020
Although little evidence exists with regard to how to best treat patients with breast cancer during the COVID-19 pandemic, guidelines have been issued by organizations like ESMO to assist providers with making those decisions.
Seattle Cancer Care Alliance Releases Guidance for Managing Hematologic Malignancies During COVID-19 CrisisMay 18th 2020
Mary-Beth Percival, MD, provides insight into precautionary measures put into place to ensure patient safety, some of the considerations included in the paper, and the different ways in which she is overcoming challenges faced in practice in light of the pandemic.
Dr. Huh on SGO COVID-19 Task Force EffortsMay 15th 2020
Warner K. Huh, MD, discusses some of the key challenges faced in the management of gynecologic cancers in light of the COVID-19 crisis, shares some of the resources provided by the SGO COVID-19 task force, and projects what is needed to quell the pandemic, which he refers to as version of the Great Depression.
COVID-19: The Unexpected SequelaeMay 12th 2020
History will report that the COVID-19 pandemic in Brooklyn, New York peaked on or about April 12, 2020; however, due to the protracted hospitalization experienced by severe COVID-19–positive patients, the heavy in-patient burden continues today.
SGO COVID-19 Task Force Provides Guidance During "Our Version of the Great Depression"May 11th 2020
Warner K. Huh, MD, discusses the management of gynecologic cancers during the COVID-19 era, the SGO COVID-19 task force, and what is needed to quell the pandemic, which he refers to as our version of the Great Depression.
AI System Helps Guide Care for High-Risk Patients in OncologyMay 6th 2020
In an era of value-based care, the ability to triage the needs of patients with cancer who are most likely to experience significant difficulties is becoming a priority for community oncology practices and hospital systems.
The Uromigos Unveil Updates and Insights on the Impact of COVID-19 on GU CancersMay 4th 2020
In an effort to share some of the evolving knowledge about COVID-19 and how it is impacting the healthcare system on a global scale, the Uromigos group discusses statistics, strategies, and new studies as they relate to COVID-19 and patients with genitourinary cancers.
Dr. Saba on the Impact of COVID-19 on Telehealth in Head and Neck CancerMay 4th 2020
Nabil F. Saba, MD, FACP, director, Head and Neck Medical Oncology Program, Winship Cancer Institute of Emory University, professor, Department of Hematology and Medical Oncology, Department of Otolaryngology, Emory University School of Medicine, discusses the impact of the coronavirus disease 2019 (COVID-19) on telehealth in head and neck cancer.